KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Operating Income (2016 - 2025)

Merck (MRK) has disclosed Operating Income for 17 consecutive years, with -$2.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Operating Income fell 723.1% to -$2.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.7 billion, a 1.2% decrease, with the full-year FY2025 number at $4.7 billion, down 1.22% from a year prior.
  • Operating Income was -$2.1 billion for Q4 2025 at Merck, down from $2.9 billion in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $2.9 billion in Q3 2025 to a low of -$9.4 billion in Q2 2023.
  • A 5-year average of -$276.2 million and a median of $22.5 million in 2021 define the central range for Operating Income.
  • Peak YoY movement for Operating Income: crashed 3553.51% in 2023, then skyrocketed 28800.0% in 2025.
  • Merck's Operating Income stood at $35.0 million in 2021, then crashed by 1151.43% to -$368.0 million in 2022, then tumbled by 1519.29% to -$6.0 billion in 2023, then skyrocketed by 105.74% to $342.0 million in 2024, then tumbled by 723.1% to -$2.1 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Operating Income are -$2.1 billion (Q4 2025), $2.9 billion (Q3 2025), and $1.4 billion (Q2 2025).